Returning to In-Person Instruction for K-12 Schools: Strategic Vision and Tactical Tools - POCTRN

null Returning to In-Person Instruction for K-12 Schools: Strategic Vision and Tactical Tools

Returning to In-Person Instruction for K-12 Schools

Strategic Vision and Tactical Tools


Reopening schools for in-person instruction is a national priority for the benefit of children, families, and the economy. The Centers for Disease Control and Prevention recently released a resource, Operational Strategy for K-12 Schools Through Phased Mitigation, with recommendations based on the best available evidence to enable schools to open safely and remain open. On this call, we will provide a brief overview and highlights from the resource followed by presentations on complementary tactical tools crafted by leadership from NIH’s RADx Tech initiative. These include: WhenToTest.org calculator, K-12 Playbook, Implementation Guide, and Test Connector.

Moderator

Nancy Gagliano, MD, MBA
RADx Tech, Core Lead, Large-Scale Deployment

Speakers

Neha (Kanade) Cramer, MPH 
COVID-19 Response
Lead, Schools Unit | Community Guidance Team
Community Intervention & Critical Populations Task Force (CICPTF)
Centers for Disease Control and Prevention (CDC)

Susan M. Moreira, MBA
RADx Tech Team Leader – Education

Manuel Kingsley, MBA
RADx Tech Team Leader – Implementation

When: 
March 9, 2021 
2:00PM ET

Watch the Recording >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.

ABOUT RADx

In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19